We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients. (Incorporated in Delaware) An estimated 106,000 people have been diagnosed […]

Note: Odyssey Therapeutics withdrew its IPO plans in a letter to the SEC dated June 10, 2025. Odyssey, a clinical biotech focused on autoimmune and inflammatory diseases, including ulcerative colitis, filed its S-1 on Jan. 17, 2025, without disclosing the IPO’s terms. Odyssey is a clinical-stage biopharmaceutical company led by a team and board of […]

(Note: This is a NASDAQ uplisting – a public offering – and NOT an IPO. The stock currently trades on the OTCQB.) We are a pioneer in the development, production and marketing of an innovative visualization and artificial intelligence, or AI, solution that deploys small cameras to monitor critical safety components in hard-to-reach locations and […]

(Incorporated in Delaware) Note: Wellgistics Health (WGRX Proposed) was formerly known as Danam Health.  Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division […]

We are a newly organized blank check company. (Incorporated in the Cayman Islands) We were founded by two Greek shipping executives, Prokopios Tsirigakis and George Syllantavos. They are the co-CEOs of Nautilus Energy Management, a maritime energy services company.  (Note: Stellar V Capital Corp. disclosed the terms for its SPAC IPO on Dec. 4, 2024, in […]

We are a clinical biopharmaceutical company developing MET-097i as an injectable treatment for obesity in a Phase I/Phase 2 clinical trial with overweight or obese healthy volunteers. (Incorporated in Delaware) We are developing next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Obesity and overweight are […]

(Incorporated in Delaware) We specialize in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Our integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense (“DoD”) and space sector […]

We provide enterprises with customized identity security software. (Incorporated in Delaware) We offer a range of solutions to meet the varied needs of our customers across multiple deployment options, including Identity Security Cloud, our SaaS-based cloud solution built on our unified platform, Atlas, and IdentityIQ, our customer-hosted identity security solution. These solutions are designed to […]

We are a blank check company, incorporated in 2024, with a focus on the technology sector, specifically semiconductors and systems solutions. (Incorporated in the Cayman Islands) Initially, we will look at companies that are poised for growth, led by a highly regarded management team, with an enterprise value in the range of $200 million to […]

We are a blank check company. (Incorporated in the Cayman Islands) Our efforts to identify a prospective target business will not be limited to a particular industry or geographic location. We do not have any specific business combination under consideration.  As a blank check company incorporated for the purpose of effecting a business combination, we […]